Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO was delisted on the 16th of December, 2016.
14 hedge funds and large institutions have $633K invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
5% more capital invested
Capital invested by funds: $603K → $633K (+$30.2K)
7% less funds holding
Funds holding: 15 → 14 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$76.1K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$7.07K |
| 3 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$6.35K |
| 4 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$3.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
-$6K |
| 2 |
ECM
Estabrook Capital Management
New York
|
-$1.89K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
1
Ancora Advisors
Cleveland,
Ohio
| $313K | +$76.1K | +120,850 | +32% |
|
|
MSAM
2
Moloney Securities Asset Management
Manchester,
Missouri
| $179K | +$3.77K | +5,995 | +2% |
|
|
OCG
3
Opus Capital Group
Cincinnati,
Ohio
| $35K | +$6.35K | +10,000 | +22% |
|
|
WJWM
4
Williams Jones Wealth Management
New York
| $25K | – | – | – |
|
|
GWI
5
Grace & White Inc
Ny,
New York
| $16K | – | – | – |
|
|
AIP
6
Almanack Investment Partners
Wayne,
Pennsylvania
| $14K | – | – | – |
|
|
LDB
7
Lee, Danner & Bass
Nashville,
Tennessee
| $13K | – | – | – |
|
|
8
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $11K | +$7.07K | +11,334 | +180% |
|
|
AA
9
AlphaMark Advisors
Ft. Wright,
Kentucky
| $9K | – | – | – |
|
|
GG
10
Gofen & Glossberg
Chicago,
Illinois
| $8K | – | – | – |
|
|
ECM
11
Estabrook Capital Management
New York
| $4.41K | -$1.89K | -3,000 | -30% |
|
|
BC
12
Bartlett & Co
Cincinnati,
Ohio
| $3K | – | – | – |
|
|
BCWM
13
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $2.7K | – | – | – |
|
|
KA
14
Kovack Advisors
Ft. Lauderdale,
Florida
| – | -$6K | -10,000 | Closed |
|
NWBO Hedge Fund Activity: Q2 2022 in Review
14 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q2 2022, worth a combined $633K — up 5% from $603K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NWBO and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was Ancora Advisors, adding an estimated $76.1K. The largest seller was Kovack Advisors, exiting entirely with an estimated $6K sold.
- 14 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q2 2022, down from 15 in Q1 2022.
- Funds reported $633K of Northwest Biotherapeutics, Inc. Common stock stock for Q2 2022, up 5% quarter-over-quarter.
- 0 funds opened new Northwest Biotherapeutics, Inc. Common stock positions in Q2 2022 and 1 closed out, a net change of -1 holder.
- The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q2 2022 was Ancora Advisors, an estimated $76.1K added.
- The largest Northwest Biotherapeutics, Inc. Common stock seller in Q2 2022 was Kovack Advisors, an estimated $6K sold.
Based on aggregated 13F filings for Q2 2022.